ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996

Wyden Plans Bill To Induce Drug Firms to conduct Trials

October 29, 1993

Cancer Letter Skips Next Two Weeks

September 2, 1988

Major New Grant Programs Approved In Carcinogenesis, Chemoprevention

May 9, 1980

Funding opportunities listed.

April 16, 2004

DCBD Board Okays Recompetition Of Human Tissue Network

June 30, 1989